Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

  1. Lekuona, I.
  2. Anguita, M.
  3. Zamorano, J.L.
  4. Rodríguez, J.M.
  5. Barja de Soroa, P.
  6. Pérez-Alcántara, F.
Aldizkaria:
Revista Espanola de Cardiologia

ISSN: 1579-2242,  0300-8932

Argitalpen urtea: 2019

Alea: 72

Zenbakia: 5

Orrialdeak: 398-406

Mota: Artikulua

DOI: 10.1016/J.RECESP.2018.03.017 GOOGLE SCHOLAR
Datuen iturria: Scopus